Psychoneuroendocrinology
Volume 34, Issue 3 , Pages 353-357 , April 2009

Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder

  • Kai G. Kahl

      Affiliations

    • Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
    • Department of Psychiatry and Psychotherapy, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • Corresponding Author InformationCorresponding author at: Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. Tel.: +49 511 532 2495; fax: +49 511 532 2415.
    • ,
  • Susanne Bens

      Affiliations

    • Department of Psychiatry and Psychotherapy, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • ,
  • Kristin Ziegler

      Affiliations

    • Department of Psychiatry and Psychotherapy, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • ,
  • Sebastian Rudolf

      Affiliations

    • Department of Psychiatry and Psychotherapy, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • ,
  • Andreas Kordon

      Affiliations

    • Department of Psychiatry and Psychotherapy, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • ,
  • Leif Dibbelt

      Affiliations

    • Institute for Clinical Chemistry, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • ,
  • Ulrich Schweiger

      Affiliations

    • Department of Psychiatry and Psychotherapy, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany

Received 3 October 2007 ,Revised 23 September 2008 ,Accepted 24 September 2008.

References 

  1. Bellino S, Patria L, Paradiso E, Di Lorenzo R, Zanon C, Zizza M, et al. Major depression in patients with borderline personality disorder: a clinical investigation. Can. J. Psychiatry. 2005;50:234–238
  2. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell. 1992;3:211–220
  3. Corruble E, Ginestet D, Guelfi JD. Comorbidity of personality disorders and unipolar major depression: a review. J. Affect. Disord. 1996;37:157–170
  4. Cuppett M, Latin RW. A survey of physical activity levels of certified athletic trainers. J. Athl. Train. 2002;37:281–285
  5. Dantz D, Bewersdorf J, Fruehwald-Schultes B, Kern W, Jelkmann W, Born J, et al. Vascular endothelial growth factor: an novel endocrine defensive response to hypoglycemia. J. Clin. Endocrinol. Metab. 2002;87:835–840
  6. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 2007;21:153–160
  7. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom. Med. 2001;63:619–630
  8. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch. Gen. Psychiatry. 1997;54:597–606
  9. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003;9:669–676
  10. Folkman J. Angiogenesis-dependent diseases. Semin. Oncol. 2001;28:24–31
  11. Frank MG, Der-Avakian A, Bland ST, Watkins LR, Maier SF. Stress-induced glucocorticoids suppress the antisense molecular regulation of FGF-2 expression. Psychoneuroendocrinology. 2007;32:376–384
  12. Fredriksson JM, Lindquist JM, Bronnikov G, Nedergaard J. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta-adrenoceptor cAMP/protein kinase A pathway involving Src but independently of Erk1/2. J. Biol. Chem. 2000;275:13802–13811
  13. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, et al. Peripheral blood T lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 1995;55:4140–4145
  14. Grant MB, Afzal A, Spoerri P, Pan H, Shaw LC, Mames RN. The role of growth factors in the pathogenesis of diabetic retinopathy. Expert. Opin. Invest. Drugs. 2004;13:1275–1293
  15. Greenberg DA, Jin K. From angiogenesis to neuropathology. Nature. 2005;438:954–959
  16. Hautzinger M, Bailer M, Worall H, Keller F. Beck-Depressions-Inventar (BDI). Testhandbuch (2. Auflage). Bern: Hans-Huber-Verlag; 1995;
  17. Hettland ML, Christensen IJ, Lottenburger T, Johansen JS, Svendsen MN, Hørslev-Petersen K, et al. Circulating VEGF as a biological marker in patients with rheumatoid arthritis? Preanalytical and biological variability in healthy persons and in patients. Dis. Markers. 2008;24:1–10
  18. Heuser I. The hypothalamic–pituitary–adrenal system in depression. Pharmacopsychiatry. 1998;31:10–13
  19. Iga J, Ueno S, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S, et al. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2007;31:658–663
  20. Jogems-Kosterman BJ, de Knijff DW, Kusters R, van Hoof JJ. Basal cortisol and DHEA levels in women with borderline personality disorder. J. Psychiatr. Res. 2007;41:1019–1026
  21. Kahl KG, Rudolf S, Stoeckelhuber BM, Dibbelt L, Gehl HB, Markhof K, et al. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder. Am. J. Psychiatry. 2005;162:168–174
  22. Kahl KG, Bens S, Ziegler K, Rudolf S, Dibbelt L, Kordon A, et al. Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder. Biol. Psychiatry. 2006;59:667–671
  23. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol. Psychiatry. 2003;54:216–226
  24. Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoetic, and pro-inflammatory cytokines. J. Cell. Physiol. 2007;212:702–709
  25. Lutgendorf SK, Johnson EL, Cooper B, Anderson B, Sorosky JI, Buller RE, et al. Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer. 2002;95:808–815
  26. Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 2003;9:4514–4521
  27. Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J. Clin. Psychiatry. 2002;63:126–134
  28. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol. Psychiatry. 2003;54:317–329
  29. Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E, et al. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J. Neurosci. 2003;23:10841–10851
  30. Newton SS, Duman RS. Regulation of neurogenesis and angiogenesis in depression. Curr. Neurovasc. Res. 2004;1:261–267
  31. Paques M, Massin P, Gaudric A. Growth factors and diabetic retinopathy. Diabetes Metab. 1997;23:125–130
  32. Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M, et al. The selfish brain: competition for energy resources. Neurosci. Biobehav. Rev. 2004;28:143–180
  33. Presta M, Dell’Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005;16:159–178
  34. Rossi A, Marinangeli MG, Butti G, Scinto A, Di Cicco L, Kalyvoka A, et al. Personality disorders in bipolar and depressive illness. J. Affect. Disord. 2001;65:3–8
  35. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005;29:201–217
  36. Schmitz N, Hartkamp N, Kiuse J, Franke GH, Reister G, Tress W. The Symptom Check-List-90-R (SCL-90-R): a German validation study. Qual. Life Res. 2000;9:185–193
  37. Sharma A, Greenman J, Sharp DM, Walker LG, Monson JRT. Vascular endothelial growth factor and psychosocial factors in colorectal carcinoma. Psychooncology. 2008;17:66–73
  38. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol. Psychiatry. 2003;54:269–328

PII: S0306-4530(08)00256-4

doi: 10.1016/j.psyneuen.2008.09.016

Psychoneuroendocrinology
Volume 34, Issue 3 , Pages 353-357 , April 2009

Article Tools